Advisor Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $10.3M | Buy |
67,211
+1,491
| +2% | +$228K | 0.72% | 21 |
|
|
2022
Q1 | $10.7M | Buy |
65,720
+462
| +0.7% | +$67.1K | 0.67% | 22 |
|
|
2021
Q4 | $8.84M | Buy |
65,258
+1,502
| +2% | +$177K | 0.53% | 34 |
|
|
2021
Q3 | $6.88M | Sell |
63,756
-1,556
| -2% | -$178K | 0.46% | 41 |
|
|
2021
Q2 | $7.36M | Buy |
65,312
+1,412
| +2% | +$159K | 0.48% | 38 |
|
|
2021
Q1 | $6.92M | Buy |
63,900
+127
| +0.2% | +$13.6K | 0.5% | 41 |
|
|
2020
Q4 | $6.83M | Sell |
63,773
-1,483
| -2% | -$143K | 0.51% | 40 |
|
|
2020
Q3 | $5.72M | Sell |
65,256
-4,434
| -6% | -$417K | 0.49% | 44 |
|
|
2020
Q2 | $6.84M | Buy |
69,690
+12,931
| +23% | +$1.14M | 0.64% | 32 |
|
|
2020
Q1 | $4.32M | Buy |
56,759
+9,570
| +20% | +$815K | 0.52% | 44 |
|
|
2019
Q4 | $4.21M | Buy |
47,189
+4,852
| +11% | +$403K | 0.44% | 52 |
|
|
2019
Q3 | $3.21M | Buy |
42,337
+3,646
| +9% | +$250K | 0.39% | 55 |
|
|
2019
Q2 | $2.81M | Buy |
38,691
+238
| +0.6% | +$18.7K | 0.34% | 54 |
|
|
2019
Q1 | $3.1M | Sell |
38,453
-10,407
| -21% | -$851K | 0.4% | 53 |
|
|
2018
Q4 | $4.5M | Buy |
48,860
+7,324
| +18% | +$644K | 0.72% | 26 |
|
|
2018
Q3 | $3.93M | Sell |
41,536
-459
| -1% | -$43.5K | 0.53% | 35 |
|
|
2018
Q2 | $3.89M | Buy |
41,995
+571
| +1% | +$55.8K | 0.66% | 29 |
|
|
2018
Q1 | $3.92M | Buy |
41,424
+2,599
| +7% | +$286K | 0.73% | 25 |
|
|
2017
Q4 | $4.06M | Buy |
38,825
+3,947
| +11% | +$372K | 0.73% | 29 |
|
|
2017
Q3 | $3.1M | Sell |
34,878
-203
| -0.6% | -$15.5K | 0.61% | 32 |
|
|
2017
Q2 | $2.54M | Buy |
35,081
+3,688
| +12% | +$248K | 0.6% | 35 |
|
|
2017
Q1 | $2.05M | Sell |
31,393
-301
| -0.9% | -$18.9K | 0.55% | 37 |
|
|
2016
Q4 | $1.99M | Buy |
31,694
+3,073
| +11% | +$188K | 0.6% | 34 |
|
|
2016
Q3 | $1.8M | Sell |
28,621
-1,599
| -5% | -$104K | 0.6% | 40 |
|
|
2016
Q2 | $1.87M | Buy |
30,220
+2,083
| +7% | +$127K | 0.65% | 39 |
|
|
2016
Q1 | $1.61M | Buy |
28,137
+5,153
| +22% | +$287K | 0.6% | 41 |
|
|
2015
Q4 | $1.36M | Sell |
22,984
-683
| -3% | -$39.3K | 0.46% | 60 |
|
|
2015
Q3 | $1.33M | Sell |
23,667
-513
| -2% | -$33.4K | 0.56% | 43 |
|
|
2015
Q2 | $1.45M | Buy |
24,180
+3,908
| +19% | +$255K | 0.56% | 47 |
|
|
2015
Q1 | $1.19M | Buy |
20,272
+1,093
| +6% | +$66K | 0.5% | 51 |
|
|
2014
Q4 | $1.25M | Buy |
+19,179
| New | +$1.21M | 0.55% | 47 |
|
|
2014
Q3 | – | Sell |
-18,957
| Closed | -$1.07M | – | 231 |
|
|
2014
Q2 | $1.07M | Buy |
18,957
+2,346
| +14% | +$123K | 0.53% | 50 |
|
|
2014
Q1 | $854K | Buy |
16,611
+810
| +5% | +$40.9K | 0.47% | 59 |
|
|
2013
Q4 | $834K | Buy |
15,801
+1,478
| +10% | +$72.6K | 0.48% | 55 |
|
|
2013
Q3 | $641K | Buy |
14,323
+3,183
| +29% | +$141K | 0.46% | 72 |
|
|
2013
Q2 | $461K | Buy |
+11,140
| New | +$487K | 0.38% | 92 |
|
Other funds holding ABBV
Advisor Partners's ABBV Position: Q2 2022 in Review
Advisor Partners increased its AbbVie (ABBV) stake by 2.3% in Q2 2022, buying an estimated $228K and bringing the position to 67,211 shares worth $10.3M. The position accounts for 0.72% of the portfolio, ranked #21.
Advisor Partners first reported a position in ABBV in Q2 2013 and has held it in 36 quarters since. The position peaked at $10.7M in Q1 2022. 3,005 funds tracked by Wall St. Rank hold ABBV as of Q2 2022.
- Advisor Partners held 67,211 shares of AbbVie worth $10.3M as of Q2 2022.
- Advisor Partners bought 1,491 AbbVie shares in Q2 2022, an estimated $228K.
- AbbVie made up 0.72% of Advisor Partners's portfolio in Q2 2022, its #21 holding.
- Advisor Partners first reported a position in AbbVie in Q2 2013 and has held it in 36 quarters since.
- Advisor Partners's AbbVie position peaked at $10.7M in Q1 2022.
- 3,005 funds tracked by Wall St. Rank held AbbVie as of Q2 2022.
Based on Advisor Partners's 13F filing for Q2 2022, filed 11 Aug 2022.